🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Investigational Drug Acquiring Popularity Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are encouraged to contact these profiles privately for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers market the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in users injecting substances of uncertain source.

Several professionals stated the popularity for the experimental drug could be connected to the rising price of approved slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the British medical regulations.

Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Platform Response and Content Removal

Based on TikTok, the platform has removed violative content and prohibited related keywords and search suggestions. The company said it was dedicated to keeping the service secure and investing in strengthening enforcement strategies.

Online Trading Activities

Research also found communities with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, positive reviews and step-by-step instructions for preparing or administering at residence.

Within moments of entering one community, a seller shared WhatsApp details, where most transactions take place. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Product Details and Pricing

Inside these communities, posts show dark colored parcels with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When asked how much time a pen should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it regularly moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they can’t verify. Even if the science behind this drug is sound, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has previously seen patients injured by self-injection from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject patients to potentially serious health risks”.